Novel and emerging therapies: thrombus-targeted fibrinolysis

G Lippi, C Mattiuzzi, EJ Favaloro - Seminars in thrombosis and …, 2013 - thieme-connect.com
Thrombolytic therapy by infusion of analogs of tissue plasminogen activator (tPA), other
recombinant-based plasminogen activators (eg, alteplase, reteplase, and tenecteplase) …
被引用次数：71 相关文章

Novel and emerging therapies: thrombus-targeted fibrinolysis

G Lippi, C Mattiuzzi… - … in Thrombosis and …, 2013 - researchoutput.csu.edu.au
Thrombolytic therapy by infusion of analogs of tissue plasminogen activator (tPA), other
recombinant-based plasminogen activators (eg, alteplase, reteplase, and tenecteplase) …

Novel and emerging therapies: thrombus-targeted fibrinolysis

G Lippi, C Mattiuzzi… - Seminars in thrombosis …, 2013 - pubmed.ncbi.nlm.nih.gov
Thrombolytic therapy by infusion of analogs of tissue plasminogen activator (tPA), other
recombinant-based plasminogen activators (eg, alteplase, reteplase, and tenecteplase) …

Novel and emerging therapies: thrombus-targeted fibrinolysis.

G Lippi, C Mattiuzzi, EJ Favaloro - Seminars in Thrombosis and …, 2012 - europepmc.org
Thrombolytic therapy by infusion of analogs of tissue plasminogen activator (tPA), other
recombinant-based plasminogen activators (eg, alteplase, reteplase, and tenecteplase) …

Novel and emerging therapies: thrombus-targeted fibrinolysis.

G Lippi, C Mattiuzzi, EJ Favaloro - SEMINARS IN THROMBOSIS AND …, 2013 - iris.univr.it
Thrombolytic therapy by infusion of analogs of tissue plasminogen activator (tPA), other
recombinant-based plasminogen activators (eg, alteplase, reteplase, and tenecteplase) …